Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -209,275 | -176,494 | -140,848 | -84,553 | 67,975 |
| Depreciation Amortization | 10,476 | 13,331 | 8,533 | 6,467 | 5,508 |
| Accounts receivable | 1,410 | 8,845 | -9,409 | -184 | -334 |
| Accounts payable and accrued liabilities | 32,998 | -6,589 | 2,628 | -821 | 4,844 |
| Other Working Capital | -51,547 | -98,293 | 228,662 | -61,078 | 87,159 |
| Other Operating Activity | 62,048 | 123,069 | 81,746 | 44,368 | 7,883 |
| Operating Cash Flow | $-153,890 | $-136,131 | $171,312 | $-95,801 | $173,035 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -246,141 | -223,391 | -240,703 | -278,964 | -35,745 |
| PPE Investments | -176,737 | -52,777 | -23,567 | -11,952 | -12,001 |
| Sale Of Investment | 326,723 | 270,751 | 122,592 | 50,138 | N/A |
| Investing Cash Flow | $-96,155 | $-5,417 | $-141,678 | $-240,778 | $-47,746 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 250,000 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 60,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -2,415 |
| Common Stock Issued | 3,053 | 5,186 | 11,305 | 257,948 | 68,797 |
| Financing Cash Flow | $253,053 | $65,186 | $11,305 | $257,948 | $66,382 |
| Exchange Rate Effect | -122 | -67 | -88 | 410 | N/A |
| Beginning Cash Position | 108,005 | 184,434 | 143,583 | 221,804 | 30,133 |
| End Cash Position | 110,891 | 108,005 | 184,434 | 143,583 | 221,804 |
| Net Cash Flow | $2,886 | $-76,429 | $40,851 | $-78,221 | $191,671 |
| Free Cash Flow | |||||
| Operating Cash Flow | -153,890 | -136,131 | 171,312 | -95,801 | 173,035 |
| Capital Expenditure | -176,737 | -52,777 | -23,567 | -11,952 | -12,001 |
| Free Cash Flow | -330,627 | -188,908 | 147,745 | -107,753 | 161,034 |